(Q24794527)

Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma

Europe PubMed Central

17 November 2019

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Inhaled corticosteroid doses in asthma: an evidence-based approach.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Second-line controller therapy for persistent asthma uncontrolled on inhaled corticosteroids: the step 3 dilemma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Inhaled fluticasone at different doses for chronic asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Inhaled fluticasone propionate for chronic asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Self-management education and regular practitioner review for adults with asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Effect of beta-agonists on inflammatory cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Update on inhaled corticosteroids: safety, compliance, and new delivery systems.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

28 September 2017

Theophylline in asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients. Japanese Pulmicort Turbuhaler study group

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Potential masking effects of salmeterol on airway inflammation in asthma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Efficacy and safety of inhaled corticosteroids. New developments

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Systemic effect comparisons of six inhaled corticosteroid preparations

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Fluticasone versus salmeterol/low-dose fluticasone for long-term asthma control

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Asthma quality of life during 1 year of treatment with budesonide with or without formoterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Effects of montelukast and budesonide on airway responses and airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

A double-blind comparison of inhaled budesonide, long-acting theophylline, and their combination in treatment of nocturnal asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

What to do at step 3 of the asthma guidelines—increase the dose of inhaled corticosteroids or add a long-acting β-agonist drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-5-17

Comparison of mometasone furoate administered by metered dose inhaler with beclomethasone dipropionate

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=528858

Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids

28 November 2018

1 reference

12 December 2020

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group

1 reference

12 December 2020

Adrenal function in adult asthmatics during long-term daily treatment with 800, 1,200, and 1,600 micrograms triamcinolone acetonide. Multicenter study

1 reference

12 December 2020

Treatment with inhaled steroids in asthma and chronic bronchitis: long-term compliance and inhaler technique

1 reference

12 December 2020

Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion

1 reference

12 December 2020

Comparison of patients' compliance with prescribed oral and inhaled asthma medications

1 reference

12 December 2020

Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance?

1 reference

12 December 2020

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

12 December 2020

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

12 December 2020

Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids

1 reference

12 December 2020

Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group

1 reference

12 December 2020

Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma

1 reference

12 December 2020

A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma. Azmacort HFA Study Group

1 reference

12 December 2020

An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma

1 reference

12 December 2020

Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler

1 reference

12 December 2020

Delayed eosinophil apoptosis in asthma

1 reference

12 December 2020

A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma

1 reference

12 December 2020

Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma

1 reference

12 December 2020

Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast

1 reference

12 December 2020

Measurement characteristics of two asthma symptom diary scales for use in clinical trials

1 reference

12 December 2020

Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma

1 reference

12 December 2020

Dose-ranging study of the clinical efficacy of twice-daily triamcinolone acetonide inhalation aerosol in moderately severe asthma

1 reference

12 December 2020

A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma

1 reference

12 December 2020

Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics

1 reference

12 December 2020

Effects of budesonide and fluticasone on 24-hour plasma cortisol. A dose-response study

1 reference

12 December 2020

Beta-adrenoceptor agonists block corticosteroid inhibition in eosinophils

1 reference

12 December 2020

Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma

1 reference

12 December 2020

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma

1 reference

12 December 2020

Comparison of 3 different doses of budesonide and placebo on the early asthmatic response to inhaled allergen

1 reference

12 December 2020

Adrenal effects and pharmacokinetics of CFC-free beclomethasone dipropionate: a 14-day dose-response study

1 reference

12 December 2020

Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases

1 reference

12 December 2020

A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients

1 reference

12 December 2020

Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment

1 reference

12 December 2020

What are minimal important changes for asthma measures in a clinical trial?

1 reference

12 December 2020

A bioassay for topical and systemic effect of three inhaled corticosteroids

1 reference

12 December 2020

Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group

1 reference

12 December 2020

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-5-17

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2068211

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1465-9921-5-17

OpenCitations bibliographic resource ID

2068211

1 reference